News Image

Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

Provided By GlobeNewswire

Last update: Apr 29, 2025

– First Level 1 study comparing an emerging technology head-to-head with RP in men with prostate cancer –

– TULSA had no blood loss and no overnight stay, along with reduced post-procedure pain, and more rapid recovery to baseline activities and overall health –

Read more at globenewswire.com

PROFOUND MEDICAL CORP

NASDAQ:PROF (9/5/2025, 8:00:01 PM)

After market: 4.17 +0.05 (+1.21%)

4.12

-0.3 (-6.79%)



Find more stocks in the Stock Screener

Follow ChartMill for more